SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-032225
Filing Date
2024-04-11
Accepted
2024-04-11 16:43:05
Documents
122
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0201701-10k_onconetix.htm   iXBRL 10-K 2848454
2 DESCRIPTION OF REGISTERED SECURITIES ea020170101ex4-2_onconetix.htm EX-4.2 25923
3 FORM OF EMPLOYMENT AGREEMENT WITH RALPH SCHIESS ea020170101ex10-21_onconetix.htm EX-10.21 77601
4 AMENDMENT TO EMPLOYMENT AGREEMENT, DATED OCTOBER 15, 2020, BY AND BETWEEN PROTEO ea020170101ex10-22_onconetix.htm EX-10.22 25436
5 AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN PROTEOMEDIX AND RALPH SCHIESS ea020170101ex10-23_onconetix.htm EX-10.23 24010
6 FORM OF EMPLOYMENT AGREEMENT WITH CHRISTIAN BRUHLMANN ea020170101ex10-24_onconetix.htm EX-10.24 75449
7 AMENDMENT TO EMPLOYMENT AGREEMENT, DATED OCTOBER 16, 2020, BY AND BETWEEN PROTEO ea020170101ex10-25_onconetix.htm EX-10.25 17894
8 AMENDMENT TO EMPLOYMENT AGREEMENT BY AND BETWEEN PROTEOMEDIX AND CHRISTIAN BRUHL ea020170101ex10-26_onconetix.htm EX-10.26 19907
9 LICENSE AGREEMENT, DATED MARCH 27, 2023, BETWEEN PROTEOMEDIX AND LABORATORY CORP ea020170101ex10-55_onconetix.htm EX-10.55 94434
10 INSIDER TRADING POLICY, ADOPTED AUGUST 7, 2023 ea020170101ex-19_onconetix.htm EX-19 108518
11 LIST OF SUBSIDIARIES ea020170101ex-21_onconetix.htm EX-21 3088
12 CONSENT OF MAYER HOFFMAN MCCANN P.C ea020170101ex23-1_onconetix.htm EX-23.1 2047
13 CONSENT OF EISNERAMPER LLP ea020170101ex23-2_onconetix.htm EX-23.2 2299
14 CERTIFICATION ea020170101ex31-1_onconetix.htm EX-31.1 12442
15 CERTIFICATION ea020170101ex31-2_onconetix.htm EX-31.2 12290
16 CERTIFICATION ea020170101ex32-1_onconetix.htm EX-32.1 5273
17 CERTIFICATION ea020170101ex32-2_onconetix.htm EX-32.2 5186
18 POLICY RELATED TO RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION, ADOPTED JANUARY ea020170101ex97_onconetix.htm EX-97.1 18138
19 GRAPHIC image_001.jpg GRAPHIC 103405
20 GRAPHIC image_002.jpg GRAPHIC 52522
21 GRAPHIC image_003.jpg GRAPHIC 48961
22 GRAPHIC image_004.jpg GRAPHIC 91323
23 GRAPHIC image_005.jpg GRAPHIC 61396
24 GRAPHIC ex19_001.jpg GRAPHIC 17228
  Complete submission text file 0001213900-24-032225.txt   13922738

Data Files

Seq Description Document Type Size
25 XBRL SCHEMA FILE bwv-20231231.xsd EX-101.SCH 112928
26 XBRL CALCULATION FILE bwv-20231231_cal.xml EX-101.CAL 92043
27 XBRL DEFINITION FILE bwv-20231231_def.xml EX-101.DEF 625793
28 XBRL LABEL FILE bwv-20231231_lab.xml EX-101.LAB 1071883
29 XBRL PRESENTATION FILE bwv-20231231_pre.xml EX-101.PRE 629590
126 EXTRACTED XBRL INSTANCE DOCUMENT ea0201701-10k_onconetix_htm.xml XML 1138488
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41294 | Film No.: 24839010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)